Skindex-29

Abstract

The Skindex-29 is a widely utilized, dermatology-specific questionnaire designed to assess the impact of various skin conditions on a patient’s health-related quality of life (QoL). This instrument specifically evaluates the extent to which a dermatological disorder has affected the respondent over the preceding week across three critical domains: physical, psychological (emotional), and social functioning.

Comprising 29 items, the scale provides a robust, patient-reported measure of disease burden. A higher resulting score signifies a greater negative impact of the skin condition on the patient’s overall well-being and quality of life.

Keywords

Skindex-29, dermatology, quality of life, QoL, skin conditions, psychometrics, symptoms, emotional impact, social functioning, questionnaire, PROM.

Authors

Chren MM (1996), de Korte J, et al. (Dutch version, 2003).

Purpose

The primary purpose of the Skindex-29 is to provide a standardized and reliable patient-reported outcome measure (PROM) specifically tailored for individuals suffering from skin diseases. It moves beyond clinical severity ratings to capture the subjective experience and life limitations imposed by the condition.

The instrument is invaluable in both clinical practice and research settings. Clinicians use it to monitor the efficacy of treatments by tracking changes in patient well-being over time, while researchers employ it to quantify the burden of disease across different dermatological populations. It provides a crucial measure of treatment success from the patient’s perspective.

Construct

The Skindex-29 measures the multidimensional construct of health-related quality of life (HRQoL) specifically related to the presence and impact of a skin disease. The 29 items are empirically grouped into three independent domains, allowing for detailed analysis of the impairment:

• Symptoms: This domain assesses physical discomfort, including sensations such as pain, itching, stinging, and burning.
• Emotions: This domain captures the psychological and emotional burden, measuring feelings like depression, anxiety, frustration, embarrassment, and self-consciousness related to the skin condition.
• Functioning: This domain evaluates limitations in daily activities and social interactions, including difficulties with work, leisure, sleep, and intimate relationships.

Validity

The validity of the Skindex-29 has been extensively established across diverse dermatological populations. Construct validity is supported by its strong correlation with clinical measures of disease severity (e.g., PASI scores for psoriasis) and with other validated generic measures of psychological distress and general health status, confirming that it accurately measures the intended construct of dermatology-specific QoL.

The differentiation between the three subscales (Symptoms, Emotions, and Functioning) has been consistently upheld through psychometric analysis, demonstrating discriminant validity. Furthermore, the scale has shown responsiveness to change, meaning scores reliably improve or worsen in tandem with clinically meaningful changes in the patient’s condition following treatment, establishing its sensitivity for outcome measurement.

Reliability

The reliability of the Skindex-29 is consistently reported as high. Internal consistency, measured by Cronbach’s alpha, typically exceeds 0.90 for the overall scale and remains robust for the individual subscales, indicating that the items within each domain are highly correlated and measure the same underlying concept.

Test-retest reliability studies have confirmed the stability of the instrument over short intervals in patients whose dermatological status has not changed significantly, ensuring that score variations reflect genuine changes in QoL rather than measurement error.

Factor Analysis

Factor analysis played a foundational role in the development and subsequent validation of the Skindex-29. Both exploratory and confirmatory factor analyses consistently support the intended three-factor structure (Symptoms, Emotions, and Functioning). This robust structure ensures that the domains are distinct yet related, providing meaningful subscale scores that clinicians and researchers can use to pinpoint specific areas of impairment.

Instrument

Test Type: Questionnaire (Patient-Reported Outcome Measure – PROM)

Format: 29 items. Responses are typically recorded on a Likert scale (e.g., ranging from 1, “Never bothered,” to 5, “Always bothered”). The recall period for the items is usually the past week.

Language Available: English, Dutch, and numerous other validated international translations.

Population Group: Patients suffering from conditions affecting the skin.

Age Group: Adults and the Elderly.

Population Details: Applicable across a wide spectrum of dermatological diagnoses, including chronic conditions such as psoriasis, eczema, acne, and generalized pruritus.

Test Methodology: The scale is self-administered. Raw scores are usually converted to a standardized 0 to 100 scale, where 0 indicates no impact on QoL and 100 indicates the maximum possible negative impact.

The original Explanation Form (Toelichtingsformulier) can be downloaded here: Skindex-29-form.pdf

The original Measurement Instrument (Meetinstrument) can be downloaded here: Skindex-29-meetinstr.pdf

The original Scoring instructions can be downloaded here: Skindex-29-scoring.pdf

Keywords

HRQoL, skin disease impact, patient-reported outcome, dermatology, Symptoms subscale, Emotions subscale, Functioning subscale, measurement instrument, chronic skin disorders.

Authors

Author ORCID Identifier: N/A (Information not provided in source.)

Affiliation Email addresses: N/A (Information not provided in source.)

Correspondence Address: N/A (Information not provided in source.)

Permissions & Fee and Test Year

The original Skindex-29 was published in 1996 by Chren MM. The Dutch adaptation was published in 2003 by de Korte J, et al. Use of the scale, particularly in commercial or large-scale research settings, may require permission and payment of a licensing fee, which should be verified by contacting the primary author or the relevant copyright holder.

Reference’s

• Chren MM, Lasek RJ, Quinn LM, Katcher ML, Koo J. (1996). Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. Journal of Investigative Dermatology, 107(5), 707–710.
• de Korte J, et al. (2003). The Dutch version of the Skindex-29: reliability and validity in a population of psoriasis patients. Acta Dermato-Venereologica, 83(1), 32–36.

Items of the Skindex-29

IMPORTANT: The following scale items must be preserved in their original language and must not be changed in any way.

The specific item text for the 29 questions was not provided in the source documentation. However, the items are distributed across the three measured domains: Symptoms, Emotions, and Functioning, reflecting the physical, psychological, and social impact of the skin condition.